Core Viewpoint - The Hong Kong stock market for new consumption has shown signs of recovery since the second half of 2024, with the company Maogeping successfully listing on the Hong Kong Stock Exchange in December 2024, achieving a stock price increase of 263% from its issue price of 29.8 HKD per share to 108.3 HKD by June 30, 2024 [1][2]. Company Performance - In 2024, Maogeping achieved a revenue of 3.885 billion RMB, representing a year-on-year growth of 34.6%, and a net profit of 881 million RMB, with a growth of 32.8% [3]. - The company's gross profit margin remained high at 84.4%, with a slight decrease of 0.4 percentage points compared to the previous year [5]. Product and Brand Analysis - Maogeping heavily relies on its single brand, MAOGEPING, which accounted for 99.3% of its revenue in the first half of 2024, raising concerns about brand sustainability [8]. - The pricing strategy of MAOGEPING products is high, with gross profit margins for color cosmetics and skincare products at 83.6% and 87.2%, respectively, indicating a significant brand premium [8][9]. Marketing and R&D Expenditure - The company has a disproportionate focus on marketing over research and development, with marketing expenses reaching 1.904 billion RMB in 2024, while R&D expenses were only 32.3 million RMB, accounting for less than 1% of revenue [9][10]. Production and Operational Model - Maogeping operates on a light-asset model, relying on external manufacturers for production, which poses long-term risks related to supply chain reliability and quality control [9][10]. Ownership Structure - The company is characterized as a family business, with the Maogeping family holding over 90% of shares prior to the IPO, raising concerns about potential conflicts of interest and governance issues [11][13]. - Prior to the IPO, the family distributed nearly 900 million RMB in dividends, which may reflect poorly on the company's image as it seeks to raise capital [15].
毛戈平股价大涨家族成员成最大获益者? 营销开支是产品成本的3倍多、生产全靠代工
Xin Lang Zheng Quan·2025-07-02 02:18